Teacher Evaluation in Practice: Implementing Chicago's REACH Students

Historically, teacher evaluation in Chicago has fallen short on two crucial fronts: It has not provided administrators with measures that differentiated among strong and weak teachers -- in fact, 93 percent of teachers were rated as Excellent or Superior -- and it has not provided teachers with useful feedback they could use to improve their instruction. Chicago is not unique -- teacher evaluation systems across the country have experienced the exact same problems.Recent national policy has emphasized overhauling these systems to include multiple measures of teacher performance, such as student outcomes, and structuring the evaluations so they are useful from both talent management and teacher professional development perspectives. Principals and teachers need an evaluation system that provides teachers with specific, practice-oriented feedback they can use to improve their instruction and school leaders need to be able to identify strong and weak teachers. Required to act by a new state law and building off lessons learned from an earlier pilot of an evidence-based observation tool, Chicago Public Schools (CPS) rolled out its new teacher evaluation system -- Recognizing Educators Advancing Chicago's Students (REACH Students) -- in the 2012-13 school year. The REACH system seeks to provide a measure of individual teacher effectiveness that can simultaneously support instructional improvement. It incorporates teacher performance ratings based on multiple classroom observations together with student growth measured on two different types of assessments. While the practice of using classroom observations as an evaluation tool is not completely new, REACH requires teachers and administrators to conceptualize classroom observations more broadly as being part of instructional improvement efforts as well as evaluation; evaluating teachers based on student test score growth has never happened before in the district. REACH implementation was a massive undertaking. It required a large-scale investment of time and energy from teachers, administrators, CPS central office staff, and the teachers union. District context played an important role and provided additional challenges as the district was introducing other major initiatives at the same time as REACH. Furthermore, the school year began with the first teacher strike in CPS in over 25 years. Teacher evaluation was one of several contentious points in the protracted negotiation, and the specific issue of using student growth on assessments to evaluate teachers received considerable coverage in the media. This report focuses on the perceptions and experiences of teachers and administrators during the first year of REACH implementation, which was in many ways a particularly demanding year. These experiences can be helpful to CPS and to other districts across the country as they work to restructure and transform teacher evaluation

The role of upstream sequences in selecting the reading frame on tmRNA

<p>Abstract</p> <p>Background</p> <p>tmRNA acts first as a tRNA and then as an mRNA to rescue stalled ribosomes in eubacteria. Two unanswered questions about tmRNA function remain: how does tmRNA, lacking an anticodon, bypass the decoding machinery and enter the ribosome? Secondly, how does the ribosome choose the proper codon to resume translation on tmRNA? According to the -1 triplet hypothesis, the answer to both questions lies in the unique properties of the three nucleotides upstream of the first tmRNA codon. These nucleotides assume an A-form conformation that mimics the codon-anticodon interaction, leading to recognition by the decoding center and choice of the reading frame. The -1 triplet hypothesis is important because it is the most credible model in which direct binding and recognition by the ribosome sets the reading frame on tmRNA.</p> <p>Results</p> <p>Conformational analysis predicts that 18 triplets cannot form the correct structure to function as the -1 triplet of tmRNA. We tested the tmRNA activity of all possible -1 triplet mutants using a genetic assay in <it>Escherichia coli</it>. While many mutants displayed reduced activity, our findings do not match the predictions of this model. Additional mutagenesis identified sequences further upstream that are required for tmRNA function. An immunoblot assay for translation of the tmRNA tag revealed that certain mutations in U85, A86, and the -1 triplet sequence result in improper selection of the first codon and translation in the wrong frame (-1 or +1) <it>in vivo</it>.</p> <p>Conclusion</p> <p>Our findings disprove the -1 triplet hypothesis. The -1 triplet is not required for accommodation of tmRNA into the ribosome, although it plays a minor role in frame selection. Our results strongly disfavor direct ribosomal recognition of the upstream sequence, instead supporting a model in which the binding of a separate ligand to A86 is primarily responsible for frame selection.</p

A Northern Survey of Gamma-Ray Blazar Candidates

In preparation for GLAST, we have compiled a sample of blazar candidates to increase the pool of well studied AGN from which GLAST counterparts will be drawn. Sources were selected with our Figure of Merit (FoM) ranking; thus, they have radio and X-ray properties very similar to the EGRET blazars. Spectroscopic confirmation of these candidates is in progress, and more than 70% of these objects have been identified as flat spectrum radio quasars and BL Lac objects. We present ~250 new optical blazar identifications based on McDonald Observatory spectroscopy, 224 with redshifts. Of these, 167 are in our FoM-selected set. To motivate the Gamma-ray nature of these objects, we analyzed the current release of the EGRET data for possible point sources at their radio positions. We develop two distinct methods to combine multiple EGRET observations of a sky position into a single detection significance. We report a detection of the signal of the set of blazar candidates in the EGRET data at the > 3 sigma level by both techniques. We predict that the majority of these blazar candidates will be found by GLAST due to its increased sensitivity, duty cycle and resolving power.Comment: ApJ Accepted (to appear 10 June 2005

Theory of mind and social judgments in people at clinical high risk of psychosis

Social cognitive deficits are consistently reported in psychotic populations. Few studies have longitudinally investigated social cognition in clinical high-risk (CHR) populations

Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery

Network-based approaches are becoming increasingly popular for drug discovery as they provide a systems-level overview of the mechanisms underlying disease pathophysiology. They have demonstrated significant early promise over other methods of biological data representation, such as in target discovery, side effect prediction and drug repurposing. In parallel, an explosion of -omics data for the deep characterization of biological systems routinely uncovers molecular signatures of disease for similar applications. Here, we present RPath, a novel algorithm that prioritizes drugs for a given disease by reasoning over causal paths in a knowledge graph (KG), guided by both drug-perturbed as well as disease-specific transcriptomic signatures. First, our approach identifies the causal paths that connect a drug to a particular disease. Next, it reasons over these paths to identify those that correlate with the transcriptional signatures observed in a drug-perturbation experiment, and anti-correlate to signatures observed in the disease of interest. The paths which match this signature profile are then proposed to represent the mechanism of action of the drug. We demonstrate how RPath consistently prioritizes clinically investigated drug-disease pairs on multiple datasets and KGs, achieving better performance over other similar methodologies. Furthermore, we present two case studies showing how one can deconvolute the predictions made by RPath as well as predict novel targets.DDF, YG, AP, CWD, BBM, DH, JR, and VC have been funded by Enveda Biosciences. This work has been funded by Enveda Biosciences (https://www.envedabio.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SM and DRB received no specific funding for this work.Peer ReviewedPostprint (author's final draft

“It’s my dream to work with Olympic athletes”: Neophyte sport psychologists’ expectations and initial experiences regarding service delivery

We examined trainee practitioners' initial experiences of applied sport psychology practice. Semi-structured interviews (4) were conducted over 6 months with 7 full-time MSc students before, during, and after the applied sport psychology module, when they were working with clients. Participants also kept reflective diaries over an 8-week period whilst working with clients. Findings included: (a) motivations and expectations of an ASP practice career, (b) perceptions of service delivery, (c) emotional demands, and (d) pivotal experiences. Findings extend previous literature on the initial stages of practitioner development, providing micro-level detail on aspects of the intense development process during this pivotal perio

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation is associated with an increased risk of stroke by a factor of 2.5; however, treatment with oral anticoagulation is of uncertain benefit.We conducted a trial involving patients with subclinical atrial fibrillation lasting 6 minutes to 24 hours. Patients were randomly assigned in a double-blind, double-dummy design to receive apixaban at a dose of 5 mg twice daily (2.5 mg twice daily when indicated) or aspirin at a dose of 81 mg daily. The trial medication was discontinued and anticoagulation started if subclinical atrial fibrillation lasting more than 24 hours or clinical atrial fibrillation developed. The primary efficacy outcome, stroke or systemic embolism, was assessed in the intention-to-treat population (all the patients who had undergone randomization); the primary safety outcome, major bleeding, was assessed in the on-treatment population (all the patients who had undergone randomization and received at least one dose of the assigned trial drug, with follow-up censored 5 days after permanent discontinuation of trial medication for any reason).We included 4012 patients with a mean (±SD) age of 76.8±7.6 years and a mean CHA2DS2-VASc score of 3.9±1.1 (scores range from 0 to 9, with higher scores indicating a higher risk of stroke); 36.1% of the patients were women. After a mean follow-up of 3.5±1.8 years, stroke or systemic embolism occurred in 55 patients in the apixaban group (0.78% per patient-year) and in 86 patients in the aspirin group (1.24% per patient-year) (hazard ratio, 0.63; 95% confidence interval [CI], 0.45 to 0.88; P = 0.007). In the on-treatment population, the rate of major bleeding was 1.71% per patient-year in the apixaban group and 0.94% per patient-year in the aspirin group (hazard ratio, 1.80; 95% CI, 1.26 to 2.57; P = 0.001). Fatal bleeding occurred in 5 patients in the apixaban group and 8 patients in the aspirin group.Among patients with subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding. (Funded by the Canadian Institutes of Health Research and others; ARTESIA ClinicalTrials.gov number, NCT01938248.)

Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke

Aims There is uncertainty about whether and how to perform screening for atrial fibrillation (AF). To estimate the incidence of previously undetected AF that would be captured using a continuous 14-day ECG monitor and the associated risk of stroke. Methods and results We analysed data from a cohort of patients >65 years old with hypertension and a pacemaker, but without known AF. For each participant, we simulated 1000 ECG monitors by randomly selecting 14-day windows in the 6 months following enrolment and calculated the average AF burden (total time in AF). We used Cox proportional hazards models adjusted for CHA(2)DS(2)-VASc score to estimate the risk of subsequent ischaemic stroke or systemic embolism (SSE) associated with burdens of AF > and 6 min was 3.10% (95% CI 2.53-3.72). This was consistent across strata of age and CHA(2)DS(2)-VASc scores. Over a mean follow-up of 2.4 years, the rate of SSE among patients with 6 min of AF. Conclusions Approximately 3% of individuals aged >65 years with hypertension may have more than 6 min of AF detected by a 14-day ECG monitor. This is associated with a stroke risk of over 2% per year. Whether oral anticoagulation will reduce stroke in these patients is unknown